cellvie

cellvie is developing cellular medicines by harnessing the therapeutic potential of mitochondria. Founded in 2018 by Drs. McCully, Schueller, del Nido, and Emani, the company builds on methods pioneered by Dr. McCully at Harvard Medical School for mitochondrial augmentation and replacement. The team is now advancing this approach as a novel treatment for ischemia-reperfusion injury, aging, and more.